A fixed-dose combination of proteolytic enzymes and a bioflavonoid, primarily used as an anti-inflammatory, anti-edematous, and fibrinolytic agent. It is widely prescribed in India for the management of post-operative and post-traumatic inflammation, swelling, and pain, as well as for venous disorders. The combination synergistically reduces inflammation, improves microcirculation, and accelerates tissue healing.
Adult: One tablet (Bromelain 90mg + Rutoside 100mg + Trypsin Chymotrypsin 50000 AU) twice daily, preferably on an empty stomach (30-60 minutes before meals or 2 hours after meals). In acute conditions, the dose may be initiated as one tablet three times daily for the first 3-4 days, then reduced to twice daily.
Note: Swallow the enteric-coated tablet whole with a glass of water. Do not crush, chew, or break. Take at least 30 minutes before food for optimal absorption. If gastrointestinal upset occurs, it may be taken with food, but efficacy may be reduced.
The combination exerts a multi-targeted anti-inflammatory and anti-edema effect. Bromelain and Trypsin-Chymotrypsin break down inflammatory mediators (bradykinin, histamine), fibrin deposits, and exudative proteins, reducing edema and improving tissue permeability. Rutoside reduces capillary fragility and permeability by inhibiting hyaluronidase and prostaglandin synthesis, thereby stabilizing vascular endothelium. Together, they enhance fibrinolysis, reduce blood viscosity, and improve microcirculation at the site of injury.
Pregnancy: Category C: Animal reproduction studies have not been conducted. Not recommended during pregnancy due to the lack of adequate and well-controlled studies. The fibrinolytic action may theoretically increase risk of bleeding.
Driving: Dizziness has been reported rarely. Patients should be cautioned about operating machinery or driving if they experience dizziness.
| Warfarin, Acenocoumarol | Increased anticoagulant effect and risk of bleeding due to antiplatelet and fibrinolytic activity of enzymes and rutoside. | Major |
| Aspirin, Clopidogrel, NSAIDs (e.g., Diclofenac) | Additive risk of gastrointestinal irritation and bleeding. | Moderate |
| Antibiotics (especially Tetracyclines, Amoxicillin) | Bromelain may increase absorption and serum levels of certain antibiotics, potentially increasing both efficacy and toxicity. | Moderate |
| Chemotherapeutic agents (e.g., 5-Fluorouracil, Vinca alkaloids) | Bromelain may enhance absorption and cytotoxicity; use only under strict supervision. | Major |
| Sedatives (e.g., Benzodiazepines, Barbiturates) | Theoretical increased sedation; limited clinical data. | Minor |
Same composition (Bromelain (90mg) + Rutoside (100mg) + Trypsin Chymotrypsin (50000AU)), different brands: